Literature DB >> 9921849

Physical rehabilitation has a positive effect on disability in multiple sclerosis patients.

A Solari1, G Filippini, P Gasco, L Colla, A Salmaggi, L La Mantia, M Farinotti, M Eoli, L Mendozzi.   

Abstract

BACKGROUND: Although physical rehabilitation is commonly administered to MS patients, its efficacy has not been established.
OBJECTIVE: We assessed the efficacy of an inpatient physical rehabilitation program on impairment, disability, and quality of life of MS patients with a randomized, single-blind, controlled trial.
METHODS: Fifty ambulatory MS patients were assigned to 3 weeks of inpatient physical rehabilitation (study treatment) or exercises performed at home (control treatment). Patients were evaluated at baseline and at 3, 9, and 15 weeks by a blinded examining physician.
RESULTS: No changes in impairment occurred in either group, as measured by the Expanded Disability Status Scale. At the end of the intervention the study group improved significantly in disability, as assessed by the Functional Independence Measure (FIM) motor domain, compared with controls (p = 0.004), and the improvement persisted at 9 weeks (p = 0.001). The effect size statistic was usually large or moderate in all scale scores of the FIM motor domain at 3 weeks and moderate to fair thereafter. The study group also improved in overall health-related quality of life profile compared with controls; however, the difference was significant only for the mental composite score at 3 (p = 0.008) and 9 weeks (p = 0.001).
CONCLUSIONS: Despite unchanging impairment, physical rehabilitation resulted in an improvement in disability and had a positive impact on mental components of health-related quality of life perception at 3 and 9 weeks.

Entities:  

Mesh:

Year:  1999        PMID: 9921849     DOI: 10.1212/wnl.52.1.57

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  35 in total

Review 1.  Neurological rehabilitation: from mechanisms to management.

Authors:  A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-12       Impact factor: 10.154

2.  The future of rehabilitation.

Authors:  R Greenwood
Journal:  BMJ       Date:  2001-11-10

3.  Symptomatic management and rehabilitation in multiple sclerosis.

Authors:  A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

Review 4.  Supporting individuals with disabling multiple sclerosis.

Authors:  Jeremy Gibson; Andrew Frank
Journal:  J R Soc Med       Date:  2002-12       Impact factor: 5.344

5.  Assessment of gait parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trial.

Authors:  Rosaria Sacco; Rita Bussman; Peter Oesch; Jürg Kesselring; Serafin Beer
Journal:  J Neurol       Date:  2010-11-15       Impact factor: 4.849

6.  Developing a wellness program for people with multiple sclerosis: description and initial results.

Authors:  Dennis L Hart; Ruth I Memoli; Brian Mason; Mark W Werneke
Journal:  Int J MS Care       Date:  2011

7.  Rehabilitation challenges in multiple sclerosis.

Authors:  Jack S Burks; George Kim Bigley; Harry Haydon Hill
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

8.  Rehabilitation in multiple sclerosis: Commentary on the recent AAN systematic review.

Authors:  Jodie K Haselkorn; Christina Hughes; Alexander Rae-Grant; Lily Jung Henson; Christopher T Bever; Albert C Lo; Theodore R Brown; George H Kraft; Gary Gronseth; Melissa J Armstrong; Pushpa Narayanaswami
Journal:  Neurol Clin Pract       Date:  2017-06

Review 9.  Multiple sclerosis.

Authors:  Richard Nicholas; Jeremy Chataway
Journal:  BMJ Clin Evid       Date:  2009-05-14

10.  Emerging evidence-based physical rehabilitation for multiple sclerosis - towards an inventory of current content across Europe.

Authors:  Kamila Rasova; Peter Feys; Thomas Henze; Hans van Tongeren; Davide Cattaneo; Johanna Jonsdottir; Alena Herbenova
Journal:  Health Qual Life Outcomes       Date:  2010-07-28       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.